Precision BioSciences, Inc.
DTIL
$4.91
$0.122.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.43% | -14.37% | -15.89% | -8.04% | -150.15% |
| Total Depreciation and Amortization | -3.16% | -1.28% | -6.87% | -25.12% | -26.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.79% | 146.03% | 181.01% | -553.90% | 91.24% |
| Change in Net Operating Assets | 171.92% | -102.39% | -243.73% | -90.90% | 122.26% |
| Cash from Operations | 24.67% | -6.40% | -1.98% | -216.02% | 60.24% |
| Capital Expenditure | 100.00% | 96.88% | 34.02% | -148.72% | -39.29% |
| Sale of Property, Plant, and Equipment | 240.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 94.00% | -- | 100.00% | -- |
| Cash from Investing | 241.67% | 96.18% | -223.71% | -51.56% | -128.57% |
| Total Debt Issued | -- | -- | -- | -100.09% | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -68.70% | -50.41% | 79.92% | 58.40% | 434.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -68.70% | -50.41% | 80.52% | 58.59% | 431.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.27% | -72.64% | 32.51% | -473.34% | 84.20% |